Effects of diethylstilbestrol (DES) medication during pregnancy: report from a symposium at the 10th International Congress of ISPOG

References

• Herbst A. L., Ulfelder H., Poskanzer D. C. Adenocarcinoma of the vagina, association of maternal stilbestrol therapy with tumor appearance in young women. N. Engl. J. Med. 1971; 284: 878–81
   PubMed Web of Science ®Google Scholar
• Herbst A. L., Kurman R. J., Scully R. E. Vaginal and cervical abnormalities after exposure to stilbestrol. in utero. Obstet. Gynecol. 1972; 40: 287–98
   PubMed Web of Science ®Google Scholar
• Kaufman R., Binder G., Gray P., Adam E. Upper genital tract changes associated with exposure in utero to DES. Am. J. Obstet. Gynecol. 1977; 128: 51–6
   PubMed Web of Science ®Google Scholar
• Kaufman R., Noller K., Adam E., Irwin J., Gray M., Jefferies J. A., Hilton J. Upper genital tract and pregnancy outcome in diethylstilbestrol-exposed progeny. Am. J. Obstet. Gynecol 1984; 148: 973–84
   PubMed Web of Science ®Google Scholar
• Cook J. W., Dodds E. C. Sex-hormones and cancer-producing compounds. Nature (London) 1933; 131: 205–6
   Google Scholar
• Dodds E. C., Goldberg L., Lawson W., Robinson R. Oestrogenic activity of certain synthetic compounds. Nature (London) 1938; 1441: 3562
   Google Scholar
• Smith O. W., Smith G. V. S., Hurwitz D. Increased excretion of pregnanediol in pregnancy from diethylstilbestrol with special reference to the prevention of late pregnancy accidents. Am. J. Obstet. Gynecol. 1946; 51: 411–15
   PubMed Web of Science ®Google Scholar
• Smith O. W. Diethylstilbestrol in the prevention and treatment of complications of pregnancy. Am. J. Obstet. Gynecol. 1948; 56: 821–34
   PubMed Web of Science ®Google Scholar
• Smith O. W., Smith G. V. S. The influence of diethylstilbestrol on the progress and outcome of pregnancy as based on a comparison of treated with untreated primigravidas. Am. J. Obstet. Gynecol. 1949; 58: 994–1009
   PubMedGoogle Scholar
• O'Rahilly R. The development of the vagina in the human. Birth Defects: Original Article Series 1977; 13: 123–36
   PubMedGoogle Scholar
• Forsberg J-G. Cervicovaginal epithelium: its origin and development. Am. J. Obstet. Gynecol. 1973; 115: 1025–43
   PubMed Web of Science ®Google Scholar
• Hailing A., Forsberg J-G. The functional importance of the oviduct in neonatally estrogenized mouse females for early embryo survival. Teratology 1992; 45: 75–82
   PubMedGoogle Scholar
• Forsberg J-G., Tenenbaum A., Rydberg C., Sernvi C. Ovarian structure and function in neonatally estrogen treated female mice. Estrogens in the Environment, J. A. McLachlan. Elsevier Publishing Co, New York 1985; 327–46, ).
   Google Scholar
• Forsberg J-G. Developmental mechanism of estrogen-induced irreversible changes in the mouse cervicovaginal epithelium. Natl. Cancer Inst. Monogr. 1979; 51: 41–56
   Google Scholar
• Taguchi O., Cunha G. R., Robboy S. J. Experimental study of the effect of diethylstilbestrol on the development of the human female reproductive tract. Biol. Res. Pregnancy Perinatol. 1983; 4: 56–70
   PubMedGoogle Scholar
• Forsberg J-G., Kalland T. Neonatal estrogen treatment and epithelial abnormalities in the cervicovaginal epithelium of adult mice. Cancer Res. 1981; 41: 721–34
   PubMed Web of Science ®Google Scholar
• Robboy S. J., Welsch W. R. Selected topics in the pathology of the vagina. Hum. Pathol. 1991; 22: 868–76
   PubMedGoogle Scholar
• Liehr J. G., Roy D. Free radical generation by redox cycling of estrogens. Ree. Radic. Biol. Med. 1990; 8: 415–23
   PubMed Web of Science ®Google Scholar
• Metzler M. The metabolism of diethylstilbestrol. CRC. Crit. Rev. Biochem. 1981; 10: 171–212
   PubMed Web of Science ®Google Scholar
• Forsberg J.-G. Estrogen effects on chromosome number and sister chromatid exchanges in uterine epithelial cells and kidney cells from neonatal mice. Teratogenesis, Carcinogenesis, and Mutagenesis 1991; 11: 135–46
   PubMedGoogle Scholar
• McLachlan J. A., Wong A., Degen G. H., Barrett J. C. Morphological and neoplastic transformation of Syrian hamster embryo fibroblasts by diethylstilbestrol and its analogs. Cancer Res. 1982; 42: 3040–5
   PubMed Web of Science ®Google Scholar
• Ozawa N., Oshimura M., McLachlan J. A., Barrett J. C. Nonrandom karyotypic changes in immortal and tumorigenic Syrian-hamster cells induced by diethylstilbestrol. Cancer Genet. 1989; 38: 271–82
   Google Scholar
• Kalland T. Long-term effects on the immune system of an early exposure to diethylstilbestrol. Banbury Report 1982; 11: 217–37
   Google Scholar
• Kalland T., Forsberg J-G. Natural killer cell activity and tumor susceptibility in female mice treated neonatally with diethylstilbestrol. Cancer Res. 1981; 41: 5134–40
   PubMed Web of Science ®Google Scholar
• Ways S. C., Mortola J. F., Zvaifler N. J., Weiss R. J., Yen S. S. C. Alteration in immune responsiveness in women exposed to diethylstilbestrol. in utero. Fertil. Steril 1987; 48: 193–7
   PubMed Web of Science ®Google Scholar
• Noller K. L., Blair P. B., O'Brien P. C., Melton L. J., Offord J. R., Kaufman R. H., Colton T. Increased occurrence of autoimmune disease among women exposed in utero to diethylstilbestrol. Fertil. Steril 1988; 49: 1080–2
   PubMed Web of Science ®Google Scholar
• Hailing A., Forsberg J-G. Effects of neonatal exposure to diethylstilbestrol on early mouse embryo development in vivo. in vitro. Biol. Reprod. 1991; 45: 157–62
   PubMedGoogle Scholar
• Hailing A., Von Mecklenburg C., Forsberg J-G. Factors of importance for decreased early embryo survival in female mice neonatally treated with diethylstilbestrol. J. Reprod. Fertil 1993, in press
   Google Scholar
• Herbst A. L., Hubby M. M., Azizi F., Makii M. M. Reproductive and gynecologic surgical experience in diethylstilbestrol-exposed daughters. Am. J. Obstet. Gynecol 1981; 141: 1019–28
   PubMed Web of Science ®Google Scholar
• Karande V. C., Lester R. G., Muasher S. J., Jones D. L., Acosta A. A., Jones H. W. Are implantations and pregnancy outcome impaired in diethylstilbestrol-exposed women after in vitro fertilization and embryo transfer?. Fertil. Steril 1990; 54: 287–91
   PubMedGoogle Scholar
• Newbold R. R., Bullock B. C., McLachlan J. A. Uterine adenocarcinoma in mice following developmental treatment with estrogens; a model for hormonal carcinogenesis. Cancer Res. 1990; 50: 7677–81
   PubMed Web of Science ®Google Scholar
• Bern H. A., Talamantes F. J. Neonatal mouse models and their relation to disease in the human female. Developmental Effects of Diethyhtilbestrol (DES) in Pregnancy, H. A. Bern, A. L. Herbst. Thieme-Stratton Inc., New York 1981; 129–47
   Google Scholar
• Rustia M. Role of hormone imbalance in transplacental carcinogenesis induced in Syrian golden hamster by sex hormones. Natl. Cancer Inst. Monogr. 1979; 51: 77–87
   Google Scholar
• Bullock B. C., Newbold R. R., McLachlan J. A. Lesions of testis and epididymis associated with prenatal diethylstilbestrol exposure. Environm. Health Perspectives 1988; 77: 29–31
   PubMed Web of Science ®Google Scholar
• World Health Organization, International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Overall evaluations of carcinogenicity: An updating of IARC Monographs Volumes 1 to 42, Supplement 7. IARC, Lyon 1987; 273–74
   Google Scholar
• Vessey M. P., Fairweather D. V. I., Norman-Smith B., Buckley J. A randomized double-blind controlled trial of the value of stilboestrol therapy in pregnancy: long-term follow-up of mothers and their offspring. Br. J. Obstet. Gynaecol 1983; 90: 1007–17
   PubMedGoogle Scholar
• Assies J. Hyperprolactinaemia in diethylstilboestrol-exposed women. Lancet 1991; 337: 983
   PubMedGoogle Scholar
• Dieckmann W. J., Davis M. E., Rynkiewicz L. M., Pottinger R. E. Does the administration of diethylstilbestrol have therapeutic value?. Am. J. Obstet. Gynecol 1953; 65: 592–601
   PubMedGoogle Scholar
• Brackbill Y., Berendes H. W. Dangers of diethylstilbestrol: review of a 1953 paper. Lancet 1978; 2: 520
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health, Education, and Welfare, Food and Drug Administration. Certain estrogens for oral or parenteral use, drugs for human use, drug efficacy study implementation. Federal Register. 1971; 36: 21537–8
   Google Scholar
• Melnick S., Cole P., Anderson D., Herbst A. L. Rates and risks of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix. N. Engl J. Med. 1987; 316: 514–16
   PubMed Web of Science ®Google Scholar
• Kaufman R. H., Adam E., Binder G. L., Gerthoffer E. Upper genital tract changes and pregnancy outcome in offspring exposed in utero to diethylstilbestrol. Am. J. Obstet. Gynecol 1980; 137: 299–308
   PubMed Web of Science ®Google Scholar
• Vooijs G. P. Adenosis en adenocarcinoma van de vagina bij jonge vrouwen en het verband met stilbestroltoediening aan de moeder. Ned. Tijdschr. Geneeskd. 1973; 117: 1875
   Google Scholar
• Stolk J. G., Vooijs G. P. Diethylstilbestrol, zwangerschap en carcinogenese. Ned. Tijdschr. Geneeskd. 1975; 119: 1654–61
   PubMedGoogle Scholar
• Huikeshoven F. J. M., Walkenburg H. C. S. DES, meer dan een oncologisch probleem. Ned. Tijdschr. Geneeskd. 1984; 128: 1553–6
   PubMedGoogle Scholar
• Hanselaar A. G. J. M., van Leusen N. D. M., de Wilde P. C. M., Vooijs P. M. Clear cell adenocarcinoma of the cervix: a report of the Central Netherlands Registry with emphasis on early detection and prognosis. Cancer 1991; 67: 1971–8
   PubMed Web of Science ®Google Scholar
• Direcks A., Figueroa S., Mintzes B., Banta D. DES European Study: DES Action the Netherlands for the European Commission Program ‘Europe Against Cancer’. DES Action the Netherlands, Utrecht 1991
   Google Scholar
• Henry-Suchet J. Une maladie d'actualité: l'adénose vaginale. Contraception-Fertilité-Sexualité 1975; 6: 1062–80
   Google Scholar
• Barrat J., Brocheriou C., Maria B., Darbois Y., Faguer C., Hervet E. Adénocarcinome vaginal à cellules claires chez la jeune fille. J. Gynecol. Obstet. Biol. Reprod. 1975; 4: 1093–102
   PubMedGoogle Scholar
• Cabau A. Malformations utérines chez les filles exposées au Distilbène pendant leur vie embryonnaire, conséquence sur leur fécondité. Contraception-Fertilité-Sexualité 1982; 10: 447–87
   Google Scholar
• Cabau A., Adjiman M. Hormones et grossesse: résultats de l'enquěte sur le distilbène. M.G.E.N. 1982; 68: 10–11
   Google Scholar
• Escoffier-Lambiotte. Une monumentale erreur médicale: les enfants du Distilbène. Le Monde 1983; 11–12, 16 February
   Google Scholar
• Spira A., Goujard J., Henrion R., Lemerle J., Robel P., Tchoubroutsky C. L'administration de diéthylstilbestrol (DES) pendant la grossesse, un problème de santé publique. Rev. Epidemiol. Santé Publique 1989; 31: 249–72
   Google Scholar
• Pons J. C., Goujard J., Derbanne C., Tournaire M. Devenir des grossesses des patientes exposées in utero au diéthylstilbestrol. Enquěte du Collège National des Gynécologues et Obstétriciens Français. J. Gynecol. Obstet. Biol. Reprod. 1988; 17: 307–16
   PubMedGoogle Scholar
• Gerbaulet A., Charmeau L., Haie-Meder C., Castaigne D., Michel G., Flamant F., Lhomme C., Duvillard P., Prade M., Chassagne D. Les tumeurs de l'enfant et de la jeune fille: la curiethérapie dans le traitement conservateur de l'adénocarcinome à cellules claires. Deuxième Salon de Gynécologie-Obstetrique Pratique. Espace Champerret-Paris 1992
   Google Scholar
• Flamant F., Goujard J., Castaigne D., Gerbaulet A., Lemerle J. Risque d'adénocarcinome à cellules claires du vagin chez l'adolescente et la jeune femme. Contraception-Fertilité-Sexualité 1989; 17: 239–41
   Google Scholar
• Cabau A. Les dangers du Distilbène. M.G.E.N. 1992; 144: 13–15
   Google Scholar
• France, Ministère de la Santé. Exposition au DES in Utero: Prise en Charge par le Praticien. 1989
   Google Scholar
• Kjörstad K. E., Bergstro Um J., Abeler V. Klarcellede adenokarsinomer i cervix uteri og vagina hos unge kvinner i Norge. Tidskr. Nor. Laegeforen 1989; 109: 1634–7
   PubMedGoogle Scholar
• Apfel R. J., Fisher S. M. To do no harm DES and the Dilemmas of Modem Medicine. Yale University Press, New Haven, Conn 1984
   Google Scholar
• Nash S., Tilley B. C., Kurland L. T., Gundersen J., Barnes A. M., Labarthe D., Donohew P. S., Kovacs L. Identifying and Tracing a Population at Risk: The DESAD Project Experience. Am. J. Public Health 1983; 73: 253–9
   PubMed Web of Science ®Google Scholar
• Papiernik-Berkhauer E. Préface. Les Enfants du Distilbène, B. Blanc. Arnette, Paris 1991; VII–VIII, -)
   Google Scholar
• Meara J., Vessey M. P., Fairweather D. V. A randomized double-blind controlled trial of the value of diethylstilboestrol therapy in pregnancy: 35-year follow-up of mothers and their offspring. Br. J. Obstet. Gynaecol 1989; 96: 620–2
   PubMedGoogle Scholar
• Erhardt A. A., Feldman J. F., Rosen L. R., Meyer-Bahlburg H. F. L., Gruen R., Veridiano N. P., Endicott J., Cohen P. Psychopathology in prenatally DES-exposed females: current and lifetime adjustment. Psychosom. Med. 1987; 49: 193–6
   Web of Science ®Google Scholar
• Braun M. L. Still with us: Research Needs of DES-exposed. National Institutes of Health, Bethesda MD 1992
   Google Scholar
• Herbst A. L., Hubby M. M., Blough R. R., Azizi F. A comparison of pregnancy experience in DES-exposed and DES-unexposed daughters. J. Reprod. Med. 1980; 24: 62–9
   PubMed Web of Science ®Google Scholar
• Barnes A. B., Colton T., Gundersen J., Noller K. L., Tilley B. C., Strama T., Townsend D. E., Hatab P., O'Brien P. C. Fertility and outcome of pregnancy in women exposed in utero to diethylstilbestrol. N. Engl. J. Med. 1980; 320: 609–13
   Google Scholar
• Cousins L., Karp W., Lacey C., Lucas W. E. Reproductive outcome of women exposed to diethylstilbestrol. in utero. Obstet. Gynecol 1980; 56: 70–6
   PubMed Web of Science ®Google Scholar
• Mangan C. E., Borow L., Burtnett-Rubin M. M., Egan V., Giuntoli R. L., Mikuta J. J. Pregnancy outcome in 98 women exposed to diethylstilbestrol. in utero. Obstet. Gynecol. 1982; 59: 315–19
   PubMed Web of Science ®Google Scholar
• Linn S., Lieberman E., Schoenbaum S. C., Monson R. R., Stubblefield P. G., Ryan K. J. Adverse outcomes of pregnancy in women exposed to diethylstilbestrol. in utero. J. Reprod. Med. 1988; 33: 3–7
   PubMed Web of Science ®Google Scholar
• Thorp J. M., Fowler W. C., Donehoo R., Sawicki C., Bowes W. A. Antepartum and intrapartum events in women exposed in utero to diethylstilbestrol. Obstet. Gynecol. 1990; 76: 828–32
   PubMedGoogle Scholar